| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $0 | -100.0% |
| R&D Expense | $574K | +1993.8% |
| SG&A Expense | $414K | +51.8% |
| Operating Income | -$1.2M | -172.0% |
| Pre-tax Income | -$1.3M | -112.5% |
| Income Tax | $0 | — |
| Net Income | -$1.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79 | -100.0% |
| Short-term Investments | $65K | — |
| Current Assets | $174K | -79.6% |
| Total Assets | $296K | -70.2% |
| Current Liabilities | $433K | +2031.5% |
| Total Liabilities | $433K | +2031.5% |
| Stockholders' Equity | -$137K | -114.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.3M | -118.3% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $3K | +103.1% |
| Financing Cash Flow | $468K | -69.3% |
| Free Cash Flow | -$1.3M | -95.8% |
| -112.5% |